Inspired by Nature, Translated by Science

Gecko is a privately owned medical company developing innovative polymers to support tissue Healing, co-founded by Christophe Bancel and Bernard Gilly (both from the iBionext Network), Prof Jeff Karp (Harvard Medical School, Brigham and Women’s Hospital – Boston, MA, USA) and Prof Bob Langer (Massachusetts Institute of Technology – Cambridge, MA, USA) in late 2013 to advance a state-of-the-art polymer platform.

Focusing on developing a near-term translatable adhesive technology to address huge unmet needs in tissue fixation and sealing, the company has turned to nature for inspiration.
Evolution being, after all, the ultimate problem solver, Gecko has capitalized on nature’s adhesive solutions to develop products that address needs across several medical indications.

Our Technology

Gecko Biomedical’s objective is to develop bio-mechanical technologies to boost the human body’s self-healing. Our platform is based on a proprietary polymer with unique chemical and physical properties, including high viscosity, hydrophobicity and fast on demand curing for precise local delivery and in situ Fixation. Upon curing, an elastic biodegradable film is formed. The structure of the polymer is tunable, allowing customization for various applications and tissues.

Sealant and adhesives

Gecko Biomedical’s proprietary technology platforms are fully synthetic bioinspired light-activated tissue adhesives with strong adhesive and sealing capacity. The adhesives have unique chemical and physical properties, including high viscosity, hydrophobicity and on demand curing.

Contact us

Gecko Biomedical

+33 1 76 21 72 28

General information:
Partnership information:


74 rue du Faubourg Saint Antoine
75012 Paris, France
Additional Information:
RCS: Paris B 793 166 299 - SIRET: 79316629900024


Gecko Biomedical – IDV
17, rue Moreau, France
75012 Paris

Gecko Biomedical (c) 2016